Viking Therapeutics Takeover Target in Biotech Investing?
Investors increasingly ask whether Viking Therapeutics could become a takeover target. This article breaks down why b...
We compare high-return candidates for Roth IRA indexing, analyzing volatility, fees, and potential tax-free compounding effects.
28,037 articlesInvestors increasingly ask whether Viking Therapeutics could become a takeover target. This article breaks down why b...
As Intuitive Surgical prepares to report earnings, investors weigh the risk/reward of buying the stock now. This guid...
The software market's laggard this year may be near a tipping point. Snowflake's recent performance hints that AI-dri...
Palantir (PLTR) sits near $152 after a blowout Q1 2026. Investors weigh whether to buy, hold, or sell Palantir stock ...
In a pivotal speech, the former chair jerome powell sends a clear message about inflation and political pressure. Inv...
GameStop posts a strong Q1 FY26 beat and authorizes a $2 billion buyback, signaling a pivot to a cash-rich model. The...
Clean-energy demand keeps lifting the prices of platinum group metals. This report highlights the best performing pla...
Many markets are cooling after a fast run-up in the post-pandemic era. This guide highlights states where home prices...
Lucid Group stock down has turned a lot of eyes toward a bold question: should investors jump in now or wait? This ar...
Nvidia races toward a near-$5 trillion market value while its on-site cafeteria charges for many items. The contrast ...
A $1,000 investment in XRP at $0.50 grew to about $7,300 at the 2025 high. With XRP near $1.40 in 2026, investors won...
Wes Moss’s simple 6% test converts pension offers into one clear metric, helping retirees decide between a lump-sum p...